Evidence map›Paper›PMID 37432917›Full record

ArticlePloS one2023

Optimising quality of life for people living with heart failure in care homes: Protocol for the co-design and feasibility testing of a digital intervention.

James McMahon, Christine Brown Wilson, Loreena Hill, Paul Tierney, David R Thompson, Jan Cameron, Doris Yu, Debra K Moser, Karen Spilsbury, Nittaya Srisuk and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 6 countries.

James McMahonSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0003-1418-6611
Christine Brown WilsonSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.
Loreena HillSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.
Paul TierneySchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.
David R ThompsonSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.
Jan CameronSchool of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.
Doris YuSchool of Nursing, University of Hong Kong, Hong Kong, China.
Debra K MoserCollege of Nursing, University of Kentucky, Lexington, Kentucky, United States of America.
Karen SpilsburySchool of Healthcare, University of Leeds, Leeds, United Kingdom.
Nittaya SrisukFaculty of Nursing, Surat Thani Rajabhat University, Surat Thani, Thailand.
Jos M G A ScholsDepartment of Health Services Research and Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Mariëlle van der VeldenDepartment of Health Services Research and Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Gary MitchellSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0003-2133-2998
Queen's University Belfast · GBMaastricht University · NLMonash Health · AUSuratthani Rajabhat University · THUniversity of Hong Kong · HKUniversity of Kentucky · USUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart failure (HF) affects up to 64.3 million people globally. Advancements in pharmaceutical, device or surgical therapies, have led to patients living longer with HF. Heart failure affects 20% of care home residents, with these individuals presenting as older, frailer, and with more complex needs compared to those living at home. Thus, improving care home staff (e.g., registered nurse and care assistant) knowledge of HF has the potential to benefit patient care and reduce acute care utilization. Our aim is to co-design, and feasibility test, a digital intervention to improve care home staff knowledge of HF and optimise quality of life for those living with the condition in long-term residential care.

methodsUsing a logic model, three workstreams have been identified. Workstream 1 (WS1), comprised of three steps, will inform the 'inputs' of the model. First, qualitative interviews (n = 20) will be conducted with care home staff to identify facilitators and barriers in the provision of care to people with HF. Concurrently, a scoping review will be undertaken to synthesise current evidence of HF interventions within care homes. The last step will involve a Delphi study with 50-70 key stakeholders (for example care home staff, people with HF and their family and friends) to determine key education priorities related to HF. Using data from WS1, a digital intervention to improve care home staff knowledge and self-efficacy of HF will be co-designed in workstream 2 (WS2) alongside those living with HF or their carers, HF professionals, and care home staff. Lastly, workstream 3 (WS3) will involve mixed-methods feasibility testing of the digital intervention. Outcomes include staff knowledge on HF and self-efficacy in caring for HF residents, intervention usability, perceived benefits of the digital intervention on quality of life for care home residents, and care staff experience of implementing the intervention. DISCUSSION: As HF affects many care home residents, it is vital that care home staff are equipped to support people living with HF in these settings. With limited interventional research in this area, it is envisaged that the resulting digital intervention will have relevance for HF resident care both nationally and internationally.

Indexed as

Heart FailureQuality of LifeCritical CareEducational StatusFeasibility StudiesHumansReview Literature as Topic

Identifiers

PMID37432917
PMCPMC10335659
OpenAlexW4383898360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.